InvestorsHub Logo
Followers 0
Posts 8635
Boards Moderated 0
Alias Born 01/01/2012

Re: None

Tuesday, 06/12/2012 10:50:09 AM

Tuesday, June 12, 2012 10:50:09 AM

Post# of 153
VYCO
1.The company has developed the first real treatment for victims of stroke and brain injury vision loss.

2. VYCO’s VBAS system enables neurosurgeons to treat “inoperable” brain cases.

3. VYCO has no real competition in the market at this time.

4. VYCO is starting to penetrate a $20B market.

5. VYCO acquired the the NovaVision technology after previous management spent $50 mil in the development and commercialization phase. VYCO’s 2012 1st quarter revenue is up 198% over the 2011 1st quarter.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.